Manuel Gámez-Chiachio

Gasdermin B over-expression arbitrates HER2-targeted therapy resistance by inducing protective autophagy

R. Rodríguez-Barrueco, J. Arribas, G. Moreno-Bueno, 2021, bioRxiv.

Intracellular Delivery of an Antibody Targeting Gasdermin-B Reduces HER2 Breast Cancer Aggressiveness

O. Herzberg, G. Moreno-Bueno, M. Garcia‐Fuentes, 2019, Clinical Cancer Research.

Novel Therapies and Strategies to Overcome Resistance to Anti-HER2-Targeted Drugs

G. Moreno-Bueno, D. Sarrió, Manuel Gámez-Chiachio, 2022, Cancers.

In‐depth proteomics characterization of ∆Np73 effectors identifies key proteins with diagnostic potential implicated in lymphangiogenesis, vasculogenesis and metastasis in colorectal cancer

A. Guzman-Aranguez, R. Barderas, M. Fernández-Aceñero, 2022, Molecular oncology.

Gasdermin B over-expression modulates HER2-targeted therapy resistance by inducing protective autophagy through Rab7 activation

R. Rodríguez-Barrueco, J. Arribas, G. Moreno-Bueno, 2022, Journal of Experimental & Clinical Cancer Research.

Effectiveness of a novel gene nanotherapy based on putrescine for cancer treatment.

R. Piñeiro, G. Moreno-Bueno, M. de la Fuente, 2023, Biomaterials science.

Intracellular Delivery of an Antibody Targeting Gasdermin-B Reduces HER2 Breast Cancer Aggressiveness

O. Herzberg, G. Moreno-Bueno, M. Garcia‐Fuentes, 2019, Clinical Cancer Research.